BCHE and Alzheimer disease: Because acetylcholine neurotransmission in the brain is reduced in patients with Alzheimer’s disease [70], a cognitive enhancer that increases acetylcholine in synaptic terminals by inhibiting cholinesterase in the brain has been developed.